By Zach Kirkland
Piper Jaffray reiterated their hold rating on shares
of CONMED (NASDAQ:CNMD) in a research report released on Thursday morning. Piper Jaffray currently has a $51.00 price objective on the stock, up from their previous price objective of $47.00.
CONMED (NASDAQ:CNMD) opened at 53.40 on Thursday. CONMED has a 52-week low of $35.85 and a 52-week high of $54.65. The stock’s 50-day moving average is $50. and its 200-day moving average is $46.. The company has a market cap of $1.47 billion and a price-to-earnings ratio of 49.44.
CONMED (NASDAQ:CNMD) last released its earnings data on Wednesday, April 22nd. The company reported $0.42 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.43 by $0.01. The company had revenue of $177.90 million for the quarter, compared to the consensus estimate of $176.16 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 2.2% on a year-over-year basis. Analysts expect that CONMED will post $1.86 EPS for the current fiscal year.
